Turnstone Biologics Corp. (TSBX) priced its upsized IPO at $12.00 – the low end of its $12.00-to-$14.00 range – on Thursday night (July 20, 2023). The company increased the size of its IPO to 6.67 million shares (6,666,667 shares) – up from 5.8 million shares in the prospectus. The early-stage cancer biotech’s IPO raised $80.04 million. […]
July 21, 2023 Read MoreODDITY Tech, Ltd. (ODD) priced its upsized IPO at $35.00 – $1.00 above the top of its recently raised price range – in a deal that produced $423.68 million in proceeds, the Israeli beauty company said early today (Wednesday, July 19, 2023). A total of 12.11 million Class A ordinary shares (12,105,261 shares) were priced […]
July 19, 2023 Read MoreCancer biotech Turnstone Biologics (TSBX proposed) set terms for its $75.4 million IPO and launched the deal early today (Monday, July 17, 2023) for pricing at the end of the week. Turnstone’s launch marks the fourth biotech IPO this month. The La Jolla, California-based biotech plans to offer 5.8 million shares at $12.00 to $14.00. […]
July 17, 2023 Read MoreAn ODD beauty is turning heads on Wall Street. ODDITY Tech, Ltd. (ODD proposed), the Israeli company that owns the IL MAKIAGE makeup brand, is the $300 million deal atop this week’s IPO Calendar. Women love its makeup, according to the online reviews. But the Street loves ODDITY Tech’s bottom line even more: Net income […]
July 16, 2023 Read MoreCleantech SPAC Nabors Energy Transition Corp. II (NETDU) raised $300 million on Thursday night (July 13, 2023) by pricing its SPAC IPO in sync with the terms in the prospectus: 30.0 million units at $10.00 each. Each unit consists of one Class A ordinary share and one-half warrant. Citigroup and Wells Fargo Securities were the […]
July 14, 2023 Read MoreLiver disease and cancer biotech Sagimet Biosciences (SGMT) shares slipped 50 cents to open at $15.50 – down 3.13 percent from its $16.00 IPO price – in its opening trade at 12:29 p.m. EDT today – Friday, July 14, 2023 – on the NASDAQ. Volume was 314,948 shares, NASDAQ records showed. The stock recovered to trade […]
Read MoreApogee Therapeutics (APGE) shares jumped $4.50 to open at $21.50 in their NASDAQ debut today – Friday, July 14, 2023. The clinical biotech’s stock was up 26.5 percent at its opening trade at 10:47 a.m. EDT today on volume of 474,312 shares, according to NASDAQ. Apogee Therapeutics upsized its IPO by 13 percent to 17.65 million […]
Read MoreTwo biotech IPOs are set for pricing tonight. Apogee Therapeutics (APGE proposed) and Sagimet Biosciences (SGMT proposed) are on the marquee to price Thursday night (July 13, 2023). The two deals would raise a combined $325.1 million, if priced at the mid-point of their ranges. Together, they make the biotech sector’s first sizable showing on […]
July 13, 2023 Read MoreODDITY Tech (ODD proposed), the Israeli beauty brand and consumer tech platform, disclosed terms early today (Monday, July 10, 2023) for its IPO and set a pricing date for next week. (Please see the IPO Calendar for details.) The company, known for its IL MAKIAGE makeup brand, said its IPO will consist of 10.53 million shares (10,526,314 […]
July 10, 2023 Read MoreIt’s biotech Monday. Sagimet Biosciences (SGMT proposed) and Apogee Therapeutics (APGE proposed) set terms for their IPOs early today (Monday, July 10, 2023) and landed on the IPO Calendar for pricing this week. (Editor’s Note: This column, published early today, has been updated with pricing dates.) Sagimet Biosciences (SGT proposed) plans to offer 4.69 million shares […]
Read More